Acarix AS Current Valuation vs. Revenue
Based on Acarix AS's profitability indicators, Acarix AS may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Acarix AS's ability to earn profits and add value for shareholders.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
Please note, there is a significant difference between Acarix AS's value and its price as these two are different measures arrived at by different means. Investors typically determine if Acarix AS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acarix AS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
For Acarix AS profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Acarix AS to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Acarix AS utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Acarix AS's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Acarix AS over time as well as its relative position and ranking within its peers.
Acarix |
Acarix AS Revenue vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Acarix AS's current stock value. Our valuation model uses many indicators to compare Acarix AS value to that of its competitors to determine the firm's financial worth. Acarix AS is the top company in current valuation category among its peers. It also is the top company in revenue category among its peers totaling about 0.07 of Revenue per Current Valuation. The ratio of Current Valuation to Revenue for Acarix AS is roughly 13.77 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Acarix AS by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Acarix AS's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Acarix Current Valuation vs. Competition
Acarix AS is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 779.27 Million. Acarix AS holds roughly 51.77 Million in current valuation claiming about 7% of equities under Health Care industry.
Acarix Revenue vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Acarix AS |
| = | 51.77 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Acarix AS |
| = | 3.76 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Acarix Revenue vs Competition
Acarix AS is the top company in revenue category among its peers. Market size based on revenue of Health Care industry is presently estimated at about 28.52 Million. Acarix AS retains roughly 3.76 Million in revenue claiming about 13% of equities under Health Care industry.
Acarix AS Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Acarix AS, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Acarix AS will eventually generate negative long term returns. The profitability progress is the general direction of Acarix AS's change in net profit over the period of time. It can combine multiple indicators of Acarix AS, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Acarix AB , a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases primarily in Europe, China, and the United States. Acarix AB was founded in 2004 and is based in Malm, Sweden. Acarix AB operates under Medical Devices classification in Sweden and is traded on Stockholm Stock Exchange. It employs 11 people.
Acarix Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Acarix AS. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Acarix AS position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Acarix AS's important profitability drivers and their relationship over time.
Use Acarix AS in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acarix AS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acarix AS will appreciate offsetting losses from the drop in the long position's value.Acarix AS Pair Trading
Acarix AS Pair Trading Analysis
The ability to find closely correlated positions to Acarix AS could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acarix AS when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acarix AS - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acarix AS to buy it.
The correlation of Acarix AS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acarix AS moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acarix AS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acarix AS can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Acarix AS position
In addition to having Acarix AS in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Semiconductor Thematic Idea Now
Semiconductor
Companies involved in production of semiconductor and semiconductor materials. The Semiconductor theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Semiconductor Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Acarix Stock
To fully project Acarix AS's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Acarix AS at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Acarix AS's income statement, its balance sheet, and the statement of cash flows.